Literature DB >> 3131869

T cell-mediated production of tumour necrosis factor-alpha by monocytes.

J M Debets1, C J van der Linden, I E Spronken, W A Buurman.   

Abstract

The aim of this study was to examine the tumour necrosis factor (TNF)-alpha production by peripheral blood mononuclear cells activated by mitogens. Considerable amounts of TNF-alpha, ranging from 1.0 to 5.0 ng/ml, were present in the supernatants of cultures of human peripheral blood mononuclear cells (PBMC), stimulated with either the anti-CD3 monoclonal antibody OKT3 or the lectin phytohaemagglutinin (PHA). The amount of TNF-alpha secreted in the supernatant was closely correlated to the degree of T cell proliferation in such cultures, as measured by [3H]TdR incorporation. In the absence of proliferating T cells the mitogens did not induce secretion of TNF-alpha by monocytes. Supernatants of proliferating T cells were shown to induce TNF-alpha production by monocytes. The macrophage-activating factor gamma interferon (IFN-gamma) was also shown to induce, in the absence of endotoxin, TNF-alpha secretion by monocytes in a dose-dependent manner. The induction of TNF-alpha production by supernatants of proliferating T cells could largely be abrogated by passaging the supernatants on an anti-IFN-gamma column before adding them to the monocytes. It is therefore concluded from this study that the production of TNF-alpha by monocytes can be induced by proliferating T cells and that this induction can largely be attributed to the T cell lymphokine IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131869     DOI: 10.1111/j.1365-3083.1988.tb02388.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  Alterations in mononuclear cell tumour necrosis factor-alpha (TNF-alpha) response in patients on long term cuprophane haemodialysis.

Authors:  A Y Annenkov; A G Strokov; F S Baranova
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

2.  Inhibitory effect of corticosteroids on the secretion of tumour necrosis factor (TNF) by monocytes is dependent on the stimulus inducing TNF synthesis.

Authors:  J M Debets; T J Ruers; M P van der Linden; C J van der Linden; W A Buurman
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  TNF-derived peptides inhibit tumour growth and metastasis through cytolytic effects on tumour lymphatics.

Authors:  W Lu; Y Wang; Q Zhang; S Owen; M Green; T Ni; M Edwards; Y Li; L Zhang; A Harris; J-L Li; D G Jackson; S Jiang
Journal:  Clin Exp Immunol       Date:  2019-07-03       Impact factor: 4.330

4.  Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

5.  Mononuclear cells in glomeruli and cytokines in urine reflect the severity of experimental proliferative immune complex glomerulonephritis.

Authors:  B Noble; K Ren; J Taverne; J Dipirro; J Van Liew; C Dijkstra; G Janossy; L W Poulter
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

6.  Therapy with antibody to tumor necrosis factor against endotoxin shock in rabbits.

Authors:  K Ishizaki; Y Youda; D M Yoon; K Arai; T Fujita
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

7.  Epidemiological evaluation of release of monocyte TNF-alpha as an exposure and effect marker in pneumoconiosis: a five year follow up study of coal workers.

Authors:  R P Schins; P J Borm
Journal:  Occup Environ Med       Date:  1995-07       Impact factor: 4.402

8.  Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.

Authors:  E P Sampaio; A L Moreira; E N Sarno; A M Malta; G Kaplan
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

9.  Immunophenotype and Immune-Modulatory Activities of Human Fetal Cartilage-Derived Progenitor Cells.

Authors:  Su Jeong Lee; Jiyoung Kim; Woo Hee Choi; So Ra Park; Byung Hyune Choi; Byoung-Hyun Min
Journal:  Cell Transplant       Date:  2019-04-14       Impact factor: 4.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.